Disqualification: the skill of walking away

Counter-intuitive but core: great salespeople disqualify hard. Selling time is the scarcest resource; every hour on a deal that was never going to close is taken from one that could.

Weak sellers keep zombie deals alive because a fat pipeline feels safe; strong sellers treat "no, and quickly" as the second-best outcome after "yes" — which is why "tell me about a deal you walked away from" is a standard interview question.

Red flags that should trigger disqualification (or a hard conversation):

• No budget path. Not "no budget today" — early enterprise deals rarely have budget — but no plausible route to money: no economic buyer engaged, no planning cycle it could enter, a champion who goes quiet when funding comes up.
• No access to power. You've asked to meet the economic buyer and been deflected repeatedly. Either your contact lacks influence or the project lacks priority; both are fatal.
• No compelling event. Nothing forces a decision by any date (section 6). Deals without a deadline don't lose to competitors — they lose to "do nothing", drifting quarter after quarter.
• You're column fodder. Criteria plainly written around a competitor, procurement needs three quotes, and you're the third. Signs: you arrived late, criteria match a rival's spec sheet, stakeholder access is rationed.
• No pain worth money. They agree the problem exists but can't quantify what it costs. "Interesting" is not a budget line.
• Fit failure. The prospect mistreats your team, or wants a price that makes the account unprofitable to serve. Bad customers cost more than no customers — a lesson anyone who has managed client scope and budgets learns viscerally.

Disqualification isn't rudeness. Done well it sounds like: "Honestly, I don't think we'd deliver enough value to justify the spend this year — can I check back when [trigger] happens?" That builds more trust than three months of chasing, and prospects remember the vendor who told them the truth.

Field note

Every sales leader praises disqualification in the interview; fewer reward it in the Monday pipeline review, where reps are held to 3–4x pipeline-coverage targets that quietly punish anyone who culls their zombie deals. That tension is real, and navigating it — disqualifying with evidence, in the CRM, with your manager's air cover — is a political skill as much as a sales one. It's also fair game to probe in an interview: asking "how do you treat a rep who kills a big deal in the forecast for good reasons?" signals you've seen how this actually plays out.

6. Compelling events: why now, why anything, why us

A compelling event is a customer-side deadline with real consequences that forces a decision by a date: a regulatory submission, an accreditation audit, a lab relocation, an incumbent contract expiry, an NHS planning-cycle deadline, a serious incident on the risk register. Your quarter-end is not one — it changes nothing about the customer's economics.

Every deal must survive three questions, in order:

1. Why anything? Why change at all rather than do nothing? The status quo is the default winner of every enterprise evaluation — free, installed, and blameless. You beat it with quantified pain (the I in MEDDPICC): the cost of inaction made visible.
2. Why now? Why this quarter, not next year? Answered by the compelling event. You can sometimes construct urgency honestly by tying the decision to a real milestone ("if the pilot doesn't start by March, you won't have evaluation data before winter pressures") — but you cannot fabricate it, and deals without a true "why now" belong lower in the forecast.
3. Why us? Why this vendor over alternatives? Answered by your differentiation — the capabilities only you have, made decisive by getting them into the decision criteria early.

The order matters: "why us" is worthless until the first two are settled — the most polished competitive pitch loses to "let's revisit next year". In discovery, spend your questions on the first two; most sellers waste them on the third.

Voice from the field

"Plenty of companies have suffered with acknowledged pain for years. Their biggest issue is fear that the cure will hurt worse than the illness."
— Trish Bertuzzi, The Sales Development Playbook (2016)